Kala Pharmaceuticals financial statements

칼라 바이오NASDAQ:KALA · Nasdaq · Healthcare · sector #17
$0.3600-1.10%
2026-10-07 close · prelim

Kala Pharmaceuticals's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$41M.

Reported results

Kala Pharmaceuticals notifications

Quantus Signal · live data · not investment advice · Privacy Policy